Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980 Dec. 77(12):7415-9. [QxMD MEDLINE Link]. [Full Text].
Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Golde D, Gallo RC. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science. 1982 Nov 5. 218(4572):571-3. [QxMD MEDLINE Link].
Rosenblatt JD, Giorgi JV, Golde DW, et al. Integrated human T-cell leukemia virus II genome in CD8 + T cells from a patient with "atypical" hairy cell leukemia: evidence for distinct T and B cell lymphoproliferative disorders. Blood. 1988 Feb. 71(2):363-9. [QxMD MEDLINE Link].
Calattini S, Chevalier SA, Duprez R, Bassot S, Froment A, Mahieux R. Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa. Retrovirology. 2005. 2:30. [QxMD MEDLINE Link].
Mahieux R, Gessain A. HTLV-3/STLV-3 and HTLV-4 viruses: discovery, epidemiology, serology and molecular aspects. Viruses. 2011 Jul. 3 (7):1074-90. [QxMD MEDLINE Link].
Murata M, Mizusawa H, Kanazawa I, Yazawa T, Uchida Y. [An autopsy case of HTLV-I associated myelopathy (HAM) with adult T-cell leukemia (ATL)]. Rinsho Shinkeigaku. 1990 Jul. 30(7):754-9. [QxMD MEDLINE Link].
Furukawa Y, Okadome T, Tara M, Niina K, Izumo S, Osame M. Human T-cell lymphotropic virus type-I (HTLV-I)-associated myelopathy/tropical spastic paraparesis with acute type of adult T-cell leukemia. Intern Med. 1995 Nov. 34(11):1130-3. [QxMD MEDLINE Link].
Primo J, Siqueira I, Nascimento MC, et al. High HTLV-1 proviral load, a marker for HTLV-1 associated myelopathy/tropical spastic paraparesis, is also detected in patients with infective dermatitis associated with HTLV-1. Braz J Med Biol Res. 2009 Aug. 42(8):761-4. [QxMD MEDLINE Link].
Vine AM, Witkover AD, Lloyd AL, Jeffery KJ, Siddiqui A, Marshall SE. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis. 2002 Oct 1. 186(7):932-9. [QxMD MEDLINE Link].
Murphy EL, Biswas HH. Human T-cell lymphotropic virus types I and II. Mandell G, Bennett J, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, PA: Churchill Livingston / Elsevier; 2010. Ch 168.
Murphy EL, Wang B, Sacher RA, Fridey J, Smith JW, Nass CC. Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection. Emerg Infect Dis. 2004 Jan. 10(1):109-16. [QxMD MEDLINE Link].
Buggage RR. Ocular manifestations of human T-cell lymphotropic virus type 1 infection. Curr Opin Ophthalmol. 2003 Dec. 14(6):420-5. [QxMD MEDLINE Link].
Maruyama K, Nagata K, Kojima K, Inaba T, Sugita S, Mochizuki M, et al. Intraocular Invasion of Adult T-Cell Leukemia Cells without Systemic Symptoms after Cataract Surgery. Case Rep Ophthalmol. 2013. 4(3):252-6. [QxMD MEDLINE Link]. [Full Text].
Yazdanpanah MJ, Maleki M, Joneidi N, Khalighi AR, Azarpazhooh MR, Khajedaluee M, et al. Cutaneous Manifestations in HTLV-I Positive Blood Donors. Iran J Basic Med Sci. 2013 Mar. 16(3):273-7. [QxMD MEDLINE Link]. [Full Text].
Safaeian M, Wilson LE, Taylor E, Thomas DL, Vlahov D. HTLV-II and bacterial infections among injection drug users. J Acquir Immune Defic Syndr. 2000 Aug 15. 24(5):483-7. [QxMD MEDLINE Link].
Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet. 1989 Feb 25. 1(8635):441. [QxMD MEDLINE Link].
LaGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet. 1990 Dec 1. 336(8727):1345-7. [QxMD MEDLINE Link].
Primo JR, Brites C, Oliveira Mde F, Moreno-Carvalho O, Machado M, Bittencourt AL. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence. Clin Infect Dis. 2005 Aug 15. 41(4):535-41. [QxMD MEDLINE Link].
Martins FM, Casseb J, Penalva-de-Oliveira AC, de Paiva MF, Watanuki F, Ortega KL. Oral manifestations of human T-cell lymphotropic virus infection in adult patients from Brazil. Oral Dis. 2010 Mar. 16(2):167-71. [QxMD MEDLINE Link].
Lins L, de Carvalho VJ, de Almeida Rego FF, Azevedo R, Kashima S, Gallazi VN, et al. Oral health profile in patients infected with HTLV-1: clinical findings, proviral load, and molecular analysis from HTLV-1 in saliva. J Med Virol. 2012 Sep. 84(9):1428-36. [QxMD MEDLINE Link].
Garlet GP, Giozza SP, Silveira EM, Claudino M, Santos SB, Avila-Campos MJ, et al. Association of human T lymphotropic virus 1 amplification of periodontitis severity with altered cytokine expression in response to a standard periodontopathogen infection. Clin Infect Dis. 2010 Feb 1. 50(3):e11-8. [QxMD MEDLINE Link].
Biswas HH, Engstrom JW, Kaidarova Z, et al. Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathy. Neurology. 2009 Sep 8. 73(10):781-9. [QxMD MEDLINE Link]. [Full Text].
Dooneief G, Marlink R, Bell K, et al. Neurologic consequences of HTLV-II infection in injection-drug users. Neurology. 1996 Jun. 46(6):1556-60. [QxMD MEDLINE Link].
Zunt JR, Tapia K, Thiede H, Lee R, Hagan H. HTLV-2 infection in injection drug users in King County, Washington. Scand J Infect Dis. 2006. 38(8):654-63. [QxMD MEDLINE Link]. [Full Text].
Bryan ES, Tadi P. Human T Cell Lymphotropic Virus. StatPearls. 2022 Jan. [QxMD MEDLINE Link]. [Full Text].
Kalinichenko S, Komkov D, Mazurov D. HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread. Viruses. 2022 Jan 14. 14 (1):[QxMD MEDLINE Link].
Futsch N, Mahieux R, Dutartre H. HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment. Viruses. 2017 Dec 21. 10 (1):[QxMD MEDLINE Link].
Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005 Sep 5. 24(39):6058-68. [QxMD MEDLINE Link].
Perzova R, Benz P, Abbott L, Welch C, Thomas A, El Ghoul R, et al. Short communication: no evidence of HTLV-3 and HTLV-4 infection in New York State subjects at risk for retroviral infection. AIDS Res Hum Retroviruses. 2010 Nov. 26(11):1229-31. [QxMD MEDLINE Link].
Chang YB, Kaidarova Z, Hindes D, Bravo M, Kiely N, Kamel H, et al. Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors--United States, 2000-2009. J Infect Dis. 2014 Feb 15. 209(4):523-31. [QxMD MEDLINE Link]. [Full Text].
Andrade TM, Dourado I, Galvao-Castro B. Associations among HTLV-I, HTLV-II, and HIV in injecting drug users in Salvador, Brazil. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jun 1. 18(2):186-7. [QxMD MEDLINE Link].
Lee HH, Weiss SH, Brown LS, Mildvan D, Shorty V, Saravolatz L. Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA. J Infect Dis. 1990 Aug. 162(2):347-52. [QxMD MEDLINE Link].
Murphy EL, Mahieux R, de The G, et al. Molecular epidemiology of HTLV-II among United States blood donors and intravenous drug users: an age-cohort effect for HTLV-II RFLP type aO. Virology. 1998 Mar 15. 242(2):425-34. [QxMD MEDLINE Link].
Murphy EL, Watanabe K, Nass CC, Ownby H, Williams A, Nemo G. Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States. J Infect Dis. 1999 Dec. 180(6):1777-83. [QxMD MEDLINE Link].
Castilla J, Pachon I, Gonzalez MP, et al. Seroprevalence of HIV and HTLV in a representative sample of the Spanish population. Epidemiol Infect. 2000 Aug. 125(1):159-62. [QxMD MEDLINE Link].
Tajima K. Worldwide distribution of HTLV. Jpn J Cancer Res. 1998 Jan. 89(1):inside front cover. [QxMD MEDLINE Link].
Edlich RF, Arnette JA, Williams FM. Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med. 2000 Jan. 18(1):109-19. [QxMD MEDLINE Link].
Willems L, Hasegawa H, Accolla R, et al. Reducing the global burden of HTLV-1 infection: An agenda for research and action. Antiviral Res. 2017 Jan. 137:41-48. [QxMD MEDLINE Link].
Roucoux DF, Murphy EL. The epidemiology and disease outcomes of human T-lymphotropic virus type II. AIDS Rev. 2004 Jul-Sep. 6(3):144-54. [QxMD MEDLINE Link].
Cook LB, Taylor GP. HTLV-1 and HTLV-2 prevalence in the United States. J Infect Dis. 2014 Feb 15. 209(4):486-7. [QxMD MEDLINE Link].
Telzak EE, Hershow R, Kalish LA, et al. Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection. Women's Interagency HIV Study. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 15. 19(5):513-8. [QxMD MEDLINE Link].
Melo J, Beby-Defaux A, Faria C, et al. HIV and HTLV prevalences among women seen for sexually transmitted diseases or pregnancy follow-up in Maputo, Mozambique. J Acquir Immune Defic Syndr. 2000 Feb 1. 23(2):203-4. [QxMD MEDLINE Link].
Eshima N, Iwata O, Iwata S, et al. Age and gender specific prevalence of HTLV-1. J Clin Virol. 2009 Jun. 45(2):135-8. [QxMD MEDLINE Link].
Stuver SO, Tachibana N, Okayama A, Shioiri S, Tsunetoshi Y, Tsuda K, et al. Heterosexual transmission of human T cell leukemia/lymphoma virus type I among married couples in southwestern Japan: an initial report from the Miyazaki Cohort Study. J Infect Dis. 1993 Jan. 167 (1):57-65. [QxMD MEDLINE Link].
Melbye M, Poulsen AG, Gallo D, Pedersen JB, Biggar RJ, Larsen O, et al. HTLV-1 infection in a population-based cohort of older persons in Guinea-Bissau, West Africa: risk factors and impact on survival. Int J Cancer. 1998 May 4. 76 (3):293-8. [QxMD MEDLINE Link].
Roucoux DF, Wang B, Smith D, et al. A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II. J Infect Dis. 2005 May 1. 191(9):1490-7. [QxMD MEDLINE Link].
[Guideline] Khabbaz RF, Fukuda K, Kaplan JE. Guidelines for counseling human T-lymphotropic virus type I (HTLV-I)- and HTLV type II-infected persons. Transfusion. 1993 Aug. 33(8):694. [QxMD MEDLINE Link].
Busch MP, Laycock M, Kleinman SH, Wages JW Jr, Calabro M, Kaplan JE, et al. Accuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study. Blood. 1994 Feb 15. 83 (4):1143-8. [QxMD MEDLINE Link].
Cooper SA, van der Loeff MS, Taylor GP. The neurology of HTLV-1 infection. Pract Neurol. 2009 Feb. 9(1):16-26. [QxMD MEDLINE Link].
Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol. 1991 Nov. 79(3):428-37. [QxMD MEDLINE Link].
Wolfe ND, Heneine W, Carr JK, Garcia AD, Shanmugam V, Tamoufe U. Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc Natl Acad Sci U S A. 2005 May 31. 102(22):7994-9. [QxMD MEDLINE Link].
Li HC, Biggar RJ, Miley WJ, Maloney EM, Cranston B, Hanchard B. Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I. J Infect Dis. 2004 Oct 1. 190(7):1275-8. [QxMD MEDLINE Link].
Wiktor SZ, Pate EJ, Rosenberg PS, Barnett M, Palmer P, Medeiros D. Mother-to-child transmission of human T-cell lymphotropic virus type I associated with prolonged breast-feeding. J Hum Virol. 1997 Nov-Dec. 1(1):37-44. [QxMD MEDLINE Link].
Kinoshita K, Amagasaki T, Hino S, et al. Milk-borne transmission of HTLV-I from carrier mothers to their children. Jpn J Cancer Res. 1987 Jul. 78(7):674-80. [QxMD MEDLINE Link].
Iga M, Okayama A, Stuver S, Matsuoka M, Mueller N, Aoki M. Genetic evidence of transmission of human T cell lymphotropic virus type 1 between spouses. J Infect Dis. 2002 Mar 1. 185(5):691-5. [QxMD MEDLINE Link].
Manns A, Wilks RJ, Murphy EL, et al. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer. 1992 Jul 30. 51(6):886-91. [QxMD MEDLINE Link].
Yara S, Fujita J, Date H. Transmission of human T-lymphotropic virus type I by bilateral living-donor lobar lung transplantation. J Thorac Cardiovasc Surg. 2009 Jul. 138(1):255-6. [QxMD MEDLINE Link].
Gout O, Baulac M, Gessain A, et al. Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med. 1990 Feb 8. 322(6):383-8. [QxMD MEDLINE Link].
Tang AR, Taylor GP, Dhasmana D. Self-Flagellation as Possible Route of Human T-Cell Lymphotropic Virus Type-1 Transmission. Emerg Infect Dis. 2019 Apr. 25 (4):811-813. [QxMD MEDLINE Link].
Carvalho EM, Da Fonseca Porto A. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Parasite Immunol. 2004 Nov-Dec. 26(11-12):487-97. [QxMD MEDLINE Link].
Marcos LA, Terashima A, Dupont HL, Gotuzzo E. Strongyloides hyperinfection syndrome: an emerging global infectious disease. Trans R Soc Trop Med Hyg. 2008 Apr. 102(4):314-8. [QxMD MEDLINE Link].
Collins JA, Hernandez AV, Hidalgo JA, Salazar R. HTLV-I infection is not associated with a higher risk of death in Peruvian HIV-infected patients. Rev Inst Med Trop Sao Paulo. 2009 Jul-Aug. 51(4):197-201. [QxMD MEDLINE Link].
Brites C, Sampalo J, Oliveira A. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression. AIDS Rev. 2009 Jan-Mar. 11(1):8-16. [QxMD MEDLINE Link].
Hershow RC, Galai N, Fukuda K, Graber J, Vlahov D, Rezza G. An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis. 1996 Aug. 174(2):309-17. [QxMD MEDLINE Link].
Laperche S, Sauleda S, Piron M, Mühlbacher A, Schennach H, Schottstedt V, et al. Evaluation of Sensitivity and Specificity Performance of Elecsys HTLV-I/II Assay in a Multicenter Study in Europe and Japan. J Clin Microbiol. 2017 Jul. 55 (7):2180-2187. [QxMD MEDLINE Link].
da Silva Brito V, Santos FLN, Gonçalves NLS, Araujo THA, Nascimento DSV, Pereira FM, et al. Performance of Commercially Available Serological Screening Tests for Human T-Cell Lymphotropic Virus Infection in Brazil. J Clin Microbiol. 2018 Dec. 56 (12):[QxMD MEDLINE Link].
Macchi B, Balestrieri E, Mastino A. Effects of nucleoside-based antiretroviral chemotherapy on human T cell leukaemia/lymphotropic virus type 1 (HTLV-1) infection in vitro. J Antimicrob Chemother. 2003 Jun. 51(6):1327-30. [QxMD MEDLINE Link].
Poiesz B, Dube D, Dube S, et al. HTLV-II-associated cutaneous T-cell lymphoma in a patient with HIV-1 infection. N Engl J Med. 2000 Mar 30. 342(13):930-6. [QxMD MEDLINE Link].
Salemi M, Lewis M, Egan JF, Hall WW, Desmyter J, Vandamme AM. Different population dynamics of human T cell lymphotropic virus type II in intravenous drug users compared with endemically infected tribes. Proc Natl Acad Sci U S A. 1999 Nov 9. 96(23):13253-8. [QxMD MEDLINE Link]. [Full Text].